Alnylam Pharmaceuticals, Inc. (ALNY) Earnings
NASDAQ·Healthcare·Biotechnology
$226.51
-0.51%
Mkt Cap $30.46B
EPS — Estimate vs Actual
Mkt Cap
$30.46B
P/E
53.80
Fwd P/E
34.62
P/S
7.11
Rev TTM
—
EPS TTM
$4.21
NASDAQ·Healthcare·Biotechnology
$226.51
-0.51%
Mkt Cap $30.46B
Mkt Cap
$30.46B
P/E
53.80
Fwd P/E
34.62
P/S
7.11
Rev TTM
—
EPS TTM
$4.21